To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Bronchopulmonary dysplasia (BPD); acute lung injury
Patient sample, mouse and cell culture studies suggest inhibiting miR-34a could help treat
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury